BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23632449)

  • 1. Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European Cystic Fibrosis Patient Registry, 2007-2009.
    VanDevanter DR; Pasta DJ
    J Cyst Fibros; 2013 Dec; 12(6):786-9. PubMed ID: 23632449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker.
    Bakker EM; Borsboom GJ; van der Wiel-Kooij EC; Caudri D; Rosenfeld M; Tiddens HA
    Pediatr Pulmonol; 2013 Nov; 48(11):1081-8. PubMed ID: 23401260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012.
    VanDevanter DR; Pasta DJ; Konstan MW
    J Pediatr; 2014 Dec; 165(6):1091-1097.e2. PubMed ID: 25134852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirometry in early childhood in cystic fibrosis patients.
    Vilozni D; Bentur L; Efrati O; Minuskin T; Barak A; Szeinberg A; Blau H; Picard E; Kerem E; Yahav Y; Augarten A
    Chest; 2007 Feb; 131(2):356-61. PubMed ID: 17296633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth failure in cystic fibrosis.
    McNaughton SA; Stormont DA; Shepherd RW; Francis PW; Dean B
    J Paediatr Child Health; 1999 Feb; 35(1):86-92. PubMed ID: 10234643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis.
    Ranganathan SC; Bush A; Dezateux C; Carr SB; Hoo AF; Lum S; Madge S; Price J; Stroobant J; Wade A; Wallis C; Wyatt H; Stocks J
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1350-7. PubMed ID: 12421744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function in infants with cystic fibrosis diagnosed by newborn screening.
    Linnane BM; Hall GL; Nolan G; Brennan S; Stick SM; Sly PD; Robertson CF; Robinson PJ; Franklin PJ; Turner SW; Ranganathan SC;
    Am J Respir Crit Care Med; 2008 Dec; 178(12):1238-44. PubMed ID: 18787217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation.
    Hayes D; Kirkby S; Whitson BA; Black SM; Sheikh SI; Tobias JD; Mansour HM; Kopp BT
    Ann Thorac Surg; 2015 Aug; 100(2):474-9. PubMed ID: 26138770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.
    Aurora P; Gustafsson P; Bush A; Lindblad A; Oliver C; Wallis CE; Stocks J
    Thorax; 2004 Dec; 59(12):1068-73. PubMed ID: 15563707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?
    Lukic KZ; Coates AL
    Pediatr Pulmonol; 2015 Sep; 50(9):863-8. PubMed ID: 26079395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spirometry in 3- to 6-year-old children with cystic fibrosis.
    Marostica PJ; Weist AD; Eigen H; Angelicchio C; Christoph K; Savage J; Grant D; Tepper RS
    Am J Respir Crit Care Med; 2002 Jul; 166(1):67-71. PubMed ID: 12091173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of supervised training on FEV1 in cystic fibrosis: a randomised controlled trial.
    Kriemler S; Kieser S; Junge S; Ballmann M; Hebestreit A; Schindler C; Stüssi C; Hebestreit H
    J Cyst Fibros; 2013 Dec; 12(6):714-20. PubMed ID: 23588193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of salbutamol on gas compression in cystic fibrosis and asthma.
    Desmond KJ; Demizio DL; Allen PD; MacDonald ND; Coates AL
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):673-7. PubMed ID: 8118635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-specific reference equations for lung function in patients with cystic fibrosis.
    Kulich M; Rosenfeld M; Campbell J; Kronmal R; Gibson RL; Goss CH; Ramsey B
    Am J Respir Crit Care Med; 2005 Oct; 172(7):885-91. PubMed ID: 15976373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
    Rosenfeld M; VanDevanter DR; Ren CL; Elkin EP; Pasta DJ; Konstan MW; Morgan WJ;
    Pediatr Pulmonol; 2015 Sep; 50(9):856-62. PubMed ID: 26086901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cough characteristics and FVC maneuver in cystic fibrosis.
    Vilozni D; Lavie M; Ofek M; Sarouk I; Efrati O
    Respir Care; 2014 Dec; 59(12):1912-7. PubMed ID: 25249647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving rate of decline of FEV1 in young adults with cystic fibrosis.
    Que C; Cullinan P; Geddes D
    Thorax; 2006 Feb; 61(2):155-7. PubMed ID: 16384880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UCLA population studies of chronic obstructive respiratory disease. VI. Relationship of physiologic factors to rate of change in forced expiratory volume in one second and forced vital capacity.
    Detels R; Sayre JW; Tashkin DP; Massey FJ; Coulson AH; Rokaw SN
    Am Rev Respir Dis; 1984 Apr; 129(4):533-7. PubMed ID: 6711996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
    Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
    Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.